Silo Pharma (SILO) Earnings Analysis

Silo Pharma (SILO) next reports earnings on 2026-09-02, consensus EPS -0.32 USD. It has beaten estimates in 2/3 recent quarters (67%). Trailing P/E -0.62.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does SILO next report earnings?

Next earnings date2026-09-02
Consensus EPS estimate-0.32 USD
Revenue estimate0.00B

SILO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-27-0.993 USDn/an/an/a
2025-11-13-0.12 USD-0.2 USD+40%Beat
2025-08-13-0.19 USD-0.2 USD+5%Beat
2025-05-09-0.23 USD-0.21 USD-9.5%Miss

Beat rate: 2/3 (67%) over reported quarters with consensus data.

SILO valuation and analyst view

Trailing P/E-0.62
Trailing EPS-5.29941 USD
Price / book0.74
Dividend yield0.00%
Market cap0.00B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Silo Pharma (SILO)'s next earnings date?

Silo Pharma is next scheduled to report on 2026-09-02, with a consensus EPS estimate of -0.32 USD and revenue estimate of 0.00B.

Did SILO beat earnings last quarter?

Consensus estimate data was not available for SILO's 2026-03-27 report.

What is SILO's earnings track record?

Over the last 3 reported quarters with consensus data, SILO beat estimates 2 times (67%).

What is SILO's current P/E ratio and EPS?

SILO trades at a trailing P/E of -0.62 on trailing EPS of -5.299407952539918 USD.

What do analysts rate SILO?

SILO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.